CAS: 1427049-21-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Brexpiprazole-d8 REF: 4Z-B-115005CAS: | - - - | To inquire | Thu 02 Jan 25 |
 | Brexpiprazole-d8 REF: TM-T10610CAS: 1427049-21-5 | 98% | To inquire | Wed 29 Jan 25 |
 | Brexpiprazole-d8 REF: 3D-CHC04921CAS: 1427049-21-5 | Min. 95% | To inquire | Wed 12 Feb 25 |
Ref: 4Z-B-115005
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
Brexpiprazole-d8
CAS:1427049-21-5
Brexpiprazole D8 is a deuterium-modified partial agonist of 5-HT1A and dopamine receptors, with Ki values …
Formula:
C25H27N3O2S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
441.62
Ref: TM-T10610
| 1mg | 488.00 € | ||
| 5mg | 1,495.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
Brexpiprazole-d8
CAS:1427049-21-5
Brexpiprazole-d8 is an antibody that specifically binds to the activator of G protein-coupled receptors. Brexpiprazole-d8 …
Formula:
C25H35N3O2S
Purity:
Min. 95%
Molecular weight:
449.7 g/mol
Ref: 3D-CHC04921
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire |
Estimated delivery in United States, on Wednesday 12 Feb 2025
